Texas 2019 - 86th Regular

Texas House Bill HB3285 Compare Versions

OldNewDifferences
1-H.B. No. 3285
1+By: Sheffield, et al. (Senate Sponsor - Huffman) H.B. No. 3285
2+ (In the Senate - Received from the House May 13, 2019;
3+ May 14, 2019, read first time and referred to Committee on Health &
4+ Human Services; May 20, 2019, reported favorably by the following
5+ vote: Yeas 9, Nays 0; May 20, 2019, sent to printer.)
6+Click here to see the committee vote
27
38
9+ A BILL TO BE ENTITLED
410 AN ACT
511 relating to programs and initiatives to prevent and respond to
612 opioid addiction, misuse, abuse, and overdose and identify and
713 treat co-occurring substance use disorders and mental illness.
814 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
9- SECTION 1. Subchapter Z, Chapter 51, Education Code, is
10- amended by adding Section 51.9362 to read as follows:
11- Sec. 51.9362. OVERDOSE AWARENESS TRAINING FOR RESIDENTIAL
12- ADVISORS AND STUDENT ORGANIZATION OFFICERS. (a) In this section:
13- (1) "Public or private institution of higher
14- education" includes an "institution of higher education" and a
15- "private or independent institution of higher education," as those
16- terms are defined by Section 61.003.
17- (2) "Residential advisor" means a student who is
18- employed by a public or private institution of higher education to
19- serve in an advisory capacity for students living in a residential
20- facility.
21- (3) "Residential facility" means a residence used
22- exclusively for housing or boarding students or faculty of a public
23- or private institution of higher education.
24- (4) "Student organization" includes any organization
25- that is composed mostly of students enrolled at a public or private
26- institution of higher education and that:
27- (A) is registered with the institution;
28- (B) receives student organization resource fee
29- revenues or other funding from the institution; or
30- (C) is otherwise recognized as a student
31- organization by the institution.
32- (b) A public or private institution of higher education that
33- imposes any mandatory training requirements on residential
34- advisors or officers of student organizations must ensure that
35- overdose awareness and appropriate response training is included
36- with that training.
37- SECTION 2. Subchapter C, Chapter 61, Education Code, is
15+ SECTION 1. Subchapter C, Chapter 61, Education Code, is
3816 amended by adding Section 61.08205 to read as follows:
3917 Sec. 61.08205. RESEARCH ON SUBSTANCE USE DISORDERS AND
4018 ADDICTION. The board shall encourage health-related institutions,
4119 as defined by Section 62.161, as added by Chapter 448 (H.B. 7), Acts
4220 of the 84th Legislature, Regular Session, 2015, and the faculty of
4321 those institutions to individually or through collaborative effort
4422 conduct research, for public health purposes, regarding substance
4523 use disorders and addiction issues involving prescription drugs.
46- SECTION 3. Subchapter B, Chapter 531, Government Code, is
24+ SECTION 2. Subchapter B, Chapter 531, Government Code, is
4725 amended by adding Section 531.02253 to read as follows:
4826 Sec. 531.02253. TELEHEALTH TREATMENT FOR SUBSTANCE USE
4927 DISORDERS. The executive commissioner by rule shall establish a
5028 program to increase opportunities and expand access to telehealth
5129 treatment for substance use disorders in this state.
52- SECTION 4. Subchapter A, Chapter 772, Government Code, is
30+ SECTION 3. Subchapter A, Chapter 772, Government Code, is
5331 amended by adding Section 772.0078 to read as follows:
5432 Sec. 772.0078. OPIOID ANTAGONIST GRANT PROGRAM. (a) In
5533 this section:
5634 (1) "Criminal justice division" means the criminal
5735 justice division established under Section 772.006.
5836 (2) "Opioid antagonist" and "opioid-related drug
5937 overdose" have the meanings assigned by Section 483.101, Health and
6038 Safety Code.
6139 (b) The criminal justice division shall establish and
6240 administer a grant program to provide financial assistance to a law
6341 enforcement agency in this state that seeks to provide opioid
6442 antagonists to peace officers, evidence technicians, and related
6543 personnel who, in the course of performing their duties, are likely
6644 to come into contact with opioids or encounter persons suffering
6745 from an apparent opioid-related drug overdose.
6846 (c) A law enforcement agency may apply for a grant under
6947 this section only if the agency first adopts a policy addressing the
7048 usage of an opioid antagonist for a person suffering from an
7149 apparent opioid-related drug overdose.
7250 (d) In an application for a grant under this section, the
7351 law enforcement agency shall provide information to the criminal
7452 justice division about the frequency and nature of:
7553 (1) interactions between peace officers and persons
7654 suffering from an apparent opioid-related drug overdose;
7755 (2) calls for assistance based on an apparent
7856 opioid-related drug overdose; and
7957 (3) any exposure of peace officers, evidence
8058 technicians, or related personnel to opioids or suspected opioids
8159 in the course of performing their duties and any reactions by those
8260 persons to those substances.
8361 (e) A law enforcement agency receiving a grant under this
8462 section shall, as soon as practicable after receiving the grant,
8563 provide to the criminal justice division proof of purchase of the
8664 opioid antagonists.
8765 (f) The criminal justice division may use any money
8866 available for purposes of this section.
89- SECTION 5. Subtitle E, Title 2, Health and Safety Code, is
67+ SECTION 4. Subtitle E, Title 2, Health and Safety Code, is
9068 amended by adding Chapter 109 to read as follows:
9169 CHAPTER 109. STATEWIDE BEHAVIORAL HEALTH COORDINATING COUNCIL
9270 Sec. 109.001. DEFINITION. In this chapter, "council" means
9371 the Statewide Behavioral Health Coordinating Council.
9472 Sec. 109.002. STATEWIDE BEHAVIORAL HEALTH STRATEGIC PLAN.
9573 In preparing the statewide behavioral health strategic plan, the
9674 council shall incorporate, as a separate part of that plan,
9775 strategies regarding substance abuse issues that are developed by
9876 the council in cooperation with the Texas Medical Board and the
9977 Texas State Board of Pharmacy, including strategies for:
10078 (1) addressing the challenges of existing prevention,
10179 intervention, and treatment programs;
10280 (2) evaluating substance use disorder prevalence
10381 involving the abuse of opioids;
10482 (3) identifying substance abuse treatment services
10583 availability and gaps; and
10684 (4) collaborating with state agencies to expand
10785 substance abuse treatment services capacity in this state.
108- SECTION 6. Subchapter B, Chapter 461A, Health and Safety
86+ SECTION 5. Subchapter B, Chapter 461A, Health and Safety
10987 Code, is amended by adding Sections 461A.058 and 461A.059 to read as
11088 follows:
11189 Sec. 461A.058. OPIOID MISUSE PUBLIC AWARENESS CAMPAIGN.
11290 (a) The executive commissioner by rule shall develop and the
113- department shall operate a statewide public awareness campaign to
91+ department shall implement a statewide public awareness campaign to
11492 deliver public service announcements that explain and clarify
11593 certain risks related to opioid misuse, including:
11694 (1) the risk of overdose, addiction, respiratory
11795 depression, or over-sedation; and
11896 (2) risks involved in mixing opioids with alcohol or
11997 other medications.
12098 (b) This section and the statewide public awareness
12199 campaign developed under this section expire August 31, 2023.
122100 Sec. 461A.059. OPIOID ANTAGONIST PROGRAM. (a) In this
123101 section, "opioid antagonist" has the meaning assigned by Section
124102 483.101.
125103 (b) From funds available for that purpose, the executive
126- commissioner shall operate a program to provide opioid antagonists
127- for the prevention of opioid overdoses in a manner determined by the
128- executive commissioner to best accomplish that purpose.
104+ commissioner shall establish a program to provide opioid
105+ antagonists for the prevention of opioid overdoses in a manner
106+ determined by the executive commissioner to best accomplish that
107+ purpose.
129108 (c) The executive commissioner may provide opioid
130109 antagonists under the program to emergency medical services
131110 personnel, first responders, public schools, community centers,
132111 and other persons likely to be in a position to respond to an opioid
133112 overdose.
134113 (d) The commission may accept gifts, grants, and donations
135114 to be used in administering this section.
136115 (e) The executive commissioner shall adopt rules as
137116 necessary to implement this section.
138- SECTION 7. Section 481.0764, Health and Safety Code, is
117+ SECTION 6. Section 481.0764, Health and Safety Code, is
139118 amended by adding Subsection (f) to read as follows:
140119 (f) A prescriber or dispenser whose practice includes the
141120 prescription or dispensation of opioids shall annually attend at
142121 least one hour of continuing education covering best practices,
143122 alternative treatment options, and multi-modal approaches to pain
144123 management that may include physical therapy, psychotherapy, and
145124 other treatments. The board shall adopt rules to establish the
146125 content of continuing education described by this subsection. The
147126 board may collaborate with private and public institutions of
148127 higher education and hospitals in establishing the content of the
149128 continuing education. This subsection expires August 31, 2023.
150- SECTION 8. Chapter 1001, Health and Safety Code, is amended
129+ SECTION 7. Chapter 1001, Health and Safety Code, is amended
151130 by adding Subchapter K to read as follows:
152131 SUBCHAPTER K. DATA COLLECTION AND ANALYSIS REGARDING OPIOID
153132 OVERDOSE DEATHS AND CO-OCCURRING SUBSTANCE USE DISORDERS
154133 Sec. 1001.261. DATA COLLECTION AND ANALYSIS REGARDING
155134 OPIOID OVERDOSE DEATHS AND CO-OCCURRING SUBSTANCE USE DISORDERS.
156135 (a) The executive commissioner shall ensure that data is collected
157136 by the department regarding opioid overdose deaths and the
158137 co-occurrence of substance use disorders and mental illness. The
159138 department may use data collected by the vital statistics unit and
160139 any other source available to the department.
161140 (b) In analyzing data collected under this section, the
162141 department shall evaluate the capacity in this state for the
163142 treatment of co-occurring substance use disorders and mental
164143 illness.
165- SECTION 9. Subchapter B, Chapter 32, Human Resources Code,
144+ SECTION 8. Subchapter B, Chapter 32, Human Resources Code,
166145 is amended by adding Section 32.03115 to read as follows:
167146 Sec. 32.03115. REIMBURSEMENT FOR MEDICATION-ASSISTED
168147 TREATMENT FOR OPIOID OR SUBSTANCE USE DISORDER. (a) In this
169148 section, "medication-assisted opioid or substance use disorder
170149 treatment" means the use of methadone, buprenorphine, oral
171150 buprenorphine/naloxone, or naltrexone to treat opioid or substance
172151 use disorder.
173152 (b) Notwithstanding Sections 531.072 and 531.073,
174153 Government Code, or any other law and subject to Subsections (c) and
175154 (d), the commission shall provide medical assistance reimbursement
176155 for medication-assisted opioid or substance use disorder treatment
177156 without requiring a recipient of medical assistance or health care
178157 provider to obtain prior authorization or precertification for the
179158 treatment.
180159 (c) The duty to provide medical assistance reimbursement
181160 for medication-assisted opioid or substance use disorder treatment
182161 under Subsection (b) does not apply with respect to:
183162 (1) a prescription for methadone;
184163 (2) a recipient for whom medication-assisted opioid or
185164 substance use disorder treatment is determined to be medically
186165 contraindicated by the recipient's physician; or
187166 (3) a recipient who is subject to an age-related
188167 restriction applicable to medication-assisted opioid or substance
189168 abuse disorder treatment.
190169 (d) The commission may provide medical assistance
191170 reimbursement for medication-assisted opioid or substance use
192171 disorder treatment only if the treatment is prescribed to a
193172 recipient of medical assistance by a licensed health care provider
194173 who is authorized to prescribe methadone, buprenorphine, oral
195174 buprenorphine/naloxone, or naltrexone.
196175 (e) This section expires August 31, 2023.
197- SECTION 10. Section 168.002, Occupations Code, is amended
198- to read as follows:
176+ SECTION 9. Section 168.002, Occupations Code, is amended to
177+ read as follows:
199178 Sec. 168.002. EXEMPTIONS. This chapter does not apply to:
200179 (1) a medical or dental school or an outpatient clinic
201180 associated with a medical or dental school;
202181 (2) a hospital, including any outpatient facility or
203182 clinic of a hospital;
204183 (3) a hospice established under 40 T.A.C. Section
205184 97.403 or defined by 42 C.F.R. Section 418.3;
206185 (4) a facility maintained or operated by this state;
207186 (5) a clinic maintained or operated by the United
208187 States;
209188 (6) a health organization certified by the board under
210189 Section 162.001; or
211190 (7) a clinic owned or operated by a physician who
212191 treats patients within the physician's area of specialty and who
213192 personally uses other forms of treatment, including surgery, with
214193 the issuance of a prescription for a majority of the patients[; or
215194 [(8) a clinic owned or operated by an advanced
216195 practice nurse licensed in this state who treats patients in the
217196 nurse's area of specialty and who personally uses other forms of
218197 treatment with the issuance of a prescription for a majority of the
219198 patients].
220- SECTION 11. Subchapter A, Chapter 554, Occupations Code, is
199+ SECTION 10. Subchapter A, Chapter 554, Occupations Code, is
221200 amended by adding Section 554.018 to read as follows:
222201 Sec. 554.018. COMPREHENSIVE SUBSTANCE USE DISORDER
223202 APPROACH. The board shall encourage pharmacists to participate in
224203 a program that provides a comprehensive approach to the delivery of
225204 early intervention and treatment services for persons with
226205 substance use disorders and persons who are at risk of developing
227206 substance use disorders, such as a program promoted by the
228207 Substance Abuse and Mental Health Services Administration within
229208 the United States Department of Health and Human Services.
230- SECTION 12. Section 51.9362, Education Code, as added by
231- this Act, applies beginning with training required for the
232- 2019-2020 academic year.
233- SECTION 13. (a) Not later than December 1, 2019, the
234- executive commissioner of the Health and Human Services Commission
235- shall:
209+ SECTION 11. Not later than December 1, 2019, the executive
210+ commissioner of the Health and Human Services Commission shall:
236211 (1) develop the opioid misuse public awareness
237212 campaign required by Section 461A.058, Health and Safety Code, as
238213 added by this Act; and
239214 (2) establish the opioid antagonist program required
240215 by Section 461A.059, Health and Safety Code, as added by this Act.
241- (b) Notwithstanding Subsection (a) of this section, if an
242- opioid misuse public awareness campaign described by Section
243- 461A.058, Health and Safety Code, as added by this Act, is already
244- in operation as of the effective date of this Act, the Health and
245- Human Services Commission and the Department of State Health
246- Services may continue to operate that public awareness campaign to
247- satisfy the requirements of that section.
248- (c) Notwithstanding Subsection (a) of this section, if an
249- opioid antagonist program described by Section 461A.059, Health and
250- Safety Code, as added by this Act, is already in operation as of the
251- effective date of this Act, the Health and Human Services
252- Commission may continue to operate that program to satisfy the
253- requirements of that section.
254- SECTION 14. A state agency is required to implement a
255- provision of this Act only if the legislature appropriates money
256- specifically for that purpose. If the legislature does not
257- appropriate money specifically for that purpose, the state agency
258- may, but is not required to, implement a provision of this Act using
259- other appropriations available for that purpose.
260- SECTION 15. If before implementing any provision of this
216+ SECTION 12. If before implementing any provision of this
261217 Act a state agency determines that a waiver or authorization from a
262218 federal agency is necessary for implementation of that provision,
263219 the agency affected by the provision shall request the waiver or
264220 authorization and may delay implementing that provision until the
265221 waiver or authorization is granted.
266- SECTION 16. This Act takes effect September 1, 2019.
267- ______________________________ ______________________________
268- President of the Senate Speaker of the House
269- I certify that H.B. No. 3285 was passed by the House on May
270- 10, 2019, by the following vote: Yeas 119, Nays 18, 1 present, not
271- voting; and that the House concurred in Senate amendments to H.B.
272- No. 3285 on May 24, 2019, by the following vote: Yeas 124, Nays 18,
273- 2 present, not voting.
274- ______________________________
275- Chief Clerk of the House
276- I certify that H.B. No. 3285 was passed by the Senate, with
277- amendments, on May 22, 2019, by the following vote: Yeas 29, Nays
278- 2.
279- ______________________________
280- Secretary of the Senate
281- APPROVED: __________________
282- Date
283- __________________
284- Governor
222+ SECTION 13. This Act takes effect September 1, 2019.
223+ * * * * *